Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Other Working Capital Changes: 2018-2024

Historic Other Working Capital Changes for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $55.9 million.

  • Gossamer Bio's Other Working Capital Changes fell 295.33% to -$10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.1 million, marking a year-over-year decrease of 121.19%. This contributed to the annual value of $55.9 million for FY2024, which is 1336.77% up from last year.
  • As of FY2024, Gossamer Bio's Other Working Capital Changes stood at $55.9 million, which was up 1,336.77% from $3.9 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Other Working Capital Changes registered a high of $55.9 million during FY2024, and its lowest value of $2.7 million during FY2022.
  • Moreover, its 3-year median value for Other Working Capital Changes was $3.9 million (2023), whereas its average is $20.8 million.
  • In the last 5 years, Gossamer Bio's Other Working Capital Changes crashed by 35.10% in 2020 and then skyrocketed by 1,336.77% in 2024.
  • Yearly analysis of 5 years shows Gossamer Bio's Other Working Capital Changes stood at $2.9 million in 2020, then rose by 25.57% to $3.6 million in 2021, then declined by 23.99% to $2.7 million in 2022, then spiked by 43.04% to $3.9 million in 2023, then soared by 1,336.77% to $55.9 million in 2024.